LAS VEGAS, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Diabetes is a chronic disease which occurs either when the pancreas fails to develop sufficient insulin or when the human body is unable to effectively use the insulin. Symptoms associated with diabetes are frequent urination, blurred vision, increased thirst, rapid weight loss, numbness or tingling sensation in hands or feet and increased hunger. Factors which escalate the risk of diabetes are family history, ethnicity, physical inactivity, unhealthy diet, and smoking. Diabetes can damage the heart, eyes, blood vessels, kidneys, and nerves which may lead to disability and premature death. There are three types of diabetes, namely, type 1, type 2, and gestational diabetes. Type 1 diabetes can be caused by a complex interaction between genes and environmental factors. The most common risk factors for type 2 diabetes are being overweight and obesity. Type 2 diabetes is the most common type of diabetes worldwide. It is typically countered with changes in lifestyle activities such as improved diet and increased physical activity. While insulin is rarely prescribed as the initial drug for a type 2 diabetes patient, many of them may ultimately need it to control blood glucose levels. Insulin patch pumps may work very well for numerous patients suffering from type 2 diabetes.
Get a Customized Copy of this report: http://www.crystalmarketresearch.com/customization/HC07183
The development of patch pump technology has given an opportunity for improving the quality of life of a broad demographic of diabetes patients. The insulin patch pump technology offers enhanced therapeutic benefits over traditional multiple daily injection therapy. Currently available patch pumps are about the size of a computer mouse which can be directly attached to the body without any tubing. For the infusion of insulin, a small catheter is subcutaneously inserted from the underside of the patch pump. The three main components of an insulin patch pump are an insulin reservoir, a cannula and a pumping mechanism. Unlike traditional pumps, these parts are contained in a single case without any tubing. The device is directly worn on the body using an adhesive patch. The activation of the patch is programmed from a remote device and the cannula is inserted automatically.
Basal insulin comprises a majority of a person’s daily insulin requirement. It offsets the liver’s glucose secretion into the bloodstream. Every few minutes, the pancreas, in response to the liver’s secretion of glucose, secretes a small amount of insulin in the bloodstream which is known as basal insulin. Before a person develops diabetes, the pancreas regularly produces insulin proportionate to the amount of glucose present in the bloodstream. When there is a large amount of blood glucose in the body, such as after meals, the pancreas secretes larger amounts of insulin known as bolus insulin. Using patch pumps, the rate of insulin delivery can be adjusted in response to the liver’s pattern of glucose secretion.
Get a Free Sample of this report: http://www.crystalmarketresearch.com/report-sample/HC07183
The major factor responsible for the growth of the insulin pump market is increasing prevalence of diabetes. According to IDF, in 2015, diabetes affected 415 million people worldwide. This number is expected to reach up to 642 million by 2040. By 2040, 1 in 10 adults will have diabetes. With such rising incidence of diabetes around the world, the demand for insulin patch pumps is expected to increase favorably during the forecast period. As diabetic patients are becoming increasingly aware about the technologically advanced alternatives to control and manage diabetes, the insulin patch pump market will experience innovations in the near future leading to the development of new-age insulin patch pump systems with enhanced insulin delivering capabilities.
Some of the major players operating in the insulin patch pump market
- Insulet Corporation
- Debiotech S.A.
- CeQur SA
- Unilife Corporation
- Valeritas Holdings Inc.
- Cellnovo Limited.
- EOFLOW CO. LTD.
- Becton
- Dickinson and Company
Browse Complete Report: http://www.crystalmarketresearch.com/report/insulin-patch-pump-market
Key Findings of the Research Study:
- Rising incidence of diabetes around the world is expected to primarily drive the growth of insulin patch pump market during the forecast period.
- Insulin patch pump provides an efficient alternative to traditional multiple injection based insulin delivery systems.
- Development of insulin patch pumps by numerous players under pipeline will favorably contribute to the market growth over coming few years.
- North America holds the major share of the insulin patch pump market due to the commercial availability and rapid adoption of insulin patch pumps in the region.
About Crystal Market Research
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers a one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contact:
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: + 1-888-213-4282
Email: sales@crystalmarketresearch.com
Website: http://www.crystalmarketresearch.com